Literature DB >> 18510590

The complex role of vitamin D in autoimmune diseases.

P Szodoray1, B Nakken, J Gaal, R Jonsson, A Szegedi, E Zold, G Szegedi, J G Brun, R Gesztelyi, M Zeher, E Bodolay.   

Abstract

Vitamin D, besides having well-known control functions of calcium and phosphorus metabolism, bone formation and mineralization, also has a role in the maintenance of immune-homeostasis. The immune-regulatory role of vitamin D affects both the innate and adaptive immune system contributing to the immune-tolerance of self-structures. Impaired vitamin D supply/regulation, amongst other factors, leads to the development of autoimmune processes in animal models of various autoimmune diseases. The administration of vitamin D in these animals leads to improvement of immune-mediated symptoms. Moreover, in human autoimmune diseases, such as multiple sclerosis, or rheumatoid arthritis the pathogenic role of vitamin D has been described. The review aims at describing the complex immune-regulatory role of vitamin D from the cellular level through autoimmune animal models and depicting the known contribution of vitamin D in the pathogenesis of human autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510590     DOI: 10.1111/j.1365-3083.2008.02127.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  57 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

3.  Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice.

Authors:  Jin Yu; Marco Gattoni-Celli; Hong Zhu; Narayan R Bhat; Kumar Sambamurti; Sebastiano Gattoni-Celli; Mark S Kindy
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.

Authors:  Samuel Katsuyuki Shinjo; Eloisa Bonfá; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

5.  Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Allan Linneberg
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

6.  Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization.

Authors:  Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2018-05-24       Impact factor: 2.980

Review 7.  How to Boost our Immune System Against Coronavirus Infection?

Authors:  Nasrin Moazzen; Bahareh Imani; Mohammad Hassan Aelami; Nasrin Sadat Motevali Haghi; Hamid Reza Kianifar; Maryam Khoushkhui; Hamid Ahanchian
Journal:  Arch Bone Jt Surg       Date:  2020-04

8.  Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women.

Authors:  Yun Mi Choi; Won Gu Kim; Tae Yong Kim; Sung Jin Bae; Hong-Kyu Kim; Eun Kyung Jang; Min Ji Jeon; Ji Min Han; Seung Hun Lee; Jung Hwan Baek; Young Kee Shong; Won Bae Kim
Journal:  Thyroid       Date:  2014-01-30       Impact factor: 6.568

9.  The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients.

Authors:  Gabriella Czifra; Balázs Tóth; Ildikó Kovács; Tamás Bíró; Zoltán Griger; Sándor Baráth; Tünde Tarr; Margit Zeher; Sándor Sipka
Journal:  Rheumatol Int       Date:  2013-04-24       Impact factor: 2.631

10.  Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Authors:  Marcel P Stoop; Vaibhav Singh; Lennard J Dekker; Mark K Titulaer; Christoph Stingl; Peter C Burgers; Peter A E Sillevis Smitt; Rogier Q Hintzen; Theo M Luider
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.